Incretins Show Real-World Metabolic Gains Across Care Models

In adults with T2D and obesity receiving standard diabetes care, incretin therapy lowers A1c percentage, body weight, and LDL cholesterol, regardless of weight management clinic referral.
Medscape Medical News

source https://www.medscape.com/viewarticle/incretins-show-real-world-metabolic-gains-across-care-models-2026a100022k?src=rss

Comments

Popular posts from this blog

New AAFP practice guideline sets blood pressure targets for adults with hypertension